CellCarta’s sequencing platforms include NovaSeq X Plus,NovaSeq 6000,NextSeq 550Dx,and MiSeqDx. For single-cell RNA sequencing,CellCarta is a certified 10x Genomics service provider and member of their Global CRO program.
"},{"faq_question":"What spatial biology platforms are offered?","faq_answer":"Our spatial biology applications are supported by 10x Genomics Visium and Visium HD,NanoString GeoMx Digital Spatial Profiler (DSP),and Lunaphore COMET™. All instruments are cross-validated across our global sites to ensure consistent,comparable outputs regardless of where samples are processed.
"},{"faq_question":"Can CellCarta run sequencing programs globally?","faq_answer":"Yes. CellCarta operates harmonized genomics laboratories in Naperville (USA),Antwerp (Belgium),and Jining (China). Instruments and processes are cross-validated across sites,so programs that span multiple regions or require regulatory submissions in different jurisdictions receive consistent,comparable data.
"}]}#-supreme-cellcarta-service-blocks-8-713{blocks-data:[{"image":"https://cellcarta.com/wp-content/uploads/2026/07/CellCarta-808-scaled.jpg","image_alt":"High-throughput next-generation sequencing workflow for precise genetic material analysis","title":"Next-Generation Sequencing (NGS)","description":"Precise,high-throughput analysis of genetic material with both speed and scalability.","button_text":"Discover","button_url":"/capabilities/genomics/sequencing-services/ngs/","button_target":"_self"},{"image":"https://cellcarta.com/wp-content/uploads/2026/07/CellCarta-812-scaled.jpg","image_alt":"RNA sequencing workflow for transcriptome characterization and biological context analysis","title":"RNA Sequencing","description":"Cutting-edge technology to understand the transcriptome and its biological context.","button_text":"Discover","button_url":"/capabilities/genomics/sequencing-services/rnaseq/","button_target":"_self"},{"image":"https://cellcarta.com/wp-content/uploads/2026/07/CellCarta_-24-2-scaled.jpg","image_alt":"Single-cell sequencing workflow for high-resolution multi-omic cellular insight","title":"Single-Cell Sequencing","description":"High-resolution,scalable,multi-omic approaches to uncover valuable cellular insight.","button_text":"Discover","button_url":"/capabilities/genomics/sequencing-services/single-cell-sequencing/","button_target":"_self"}]}#-supreme-cellcarta-tab-content-4-713{oxy-supreme-cellcarta-tab-content-content-heading-tag:h3;oxy-supreme-cellcarta-tab-content-content-heading-size:default;oxy-supreme-cellcarta-tab-content-content-body-size:default;tabs-data:[{"tab_title":"Sequencing Platforms","content_title":"","content_body":"We have access to a vast suite of next-generation sequencing (NGS) platforms that can be tailored to your program’s specifications,including NovaSeq X Plus,NovaSeq 6000,NextSeq550Dx,MiSeqDx.
\nFor single-cell sequencing,we utilize the 10X Genomics Chromium X platform. This platform integrates whole transcriptome RNA sequencing with immune profiling and proteomics analysis for an in-depth cellular insight.
","tab_image":"https://cellcarta.com/wp-content/uploads/2026/07/CellCarta-812-scaled.jpg","image_alt":"Scientist loading samples into NovaSeq X Plus next-generation sequencing platform in a CellCarta laboratory"},{"tab_title":"Spatial Platforms","content_title":"","content_body":"For programs that require a deeper understanding of cells within their environmental context,we have a range of spatial biology platforms available for use. These include:
\nOur sequencing platforms can run a wide suite of solid tissue and liquid biopsy panels. We have validated several commercial panels for clinical use,including:
\nOur platforms can accommodate custom panels. Contact our team for further information.
","tab_image":"https://cellcarta.com/wp-content/uploads/2026/06/Panel-Selection-tab-441.jpg","image_alt":"Scientist selecting validated solid tissue and liquid biopsy panels for next-generation sequencing workflow"}]}#-supreme-cellcarta-testimonials-16-903{items-data:[{"quote":"\"Your RNAseq services are best in class and delivered lower duplication rates and much better unique read coverage.\"","author_name":"Biopharma Partner","author_role":"","author_company":""}]}